These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20706580)

  • 1. Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening.
    Mansour NR; Bickle QD
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e795. PubMed ID: 20706580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole organism high-content screening by label-free, image-based Bayesian classification for parasitic diseases.
    Paveley RA; Mansour NR; Hallyburton I; Bleicher LS; Benn AE; Mikic I; Guidi A; Gilbert IH; Hopkins AL; Bickle QD
    PLoS Negl Trop Dis; 2012; 6(7):e1762. PubMed ID: 22860151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Throughput Screening Identifies Novel Lead Compounds with Activity against Larval, Juvenile and Adult Schistosoma mansoni.
    Mansour NR; Paveley R; Gardner JM; Bell AS; Parkinson T; Bickle Q
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004659. PubMed ID: 27128493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a quantitative, high-throughput, fluorescent-based bioassay to detect schistosoma viability.
    Peak E; Chalmers IW; Hoffmann KF
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e759. PubMed ID: 20668553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays.
    Panic G; Flores D; Ingram-Sieber K; Keiser J
    Parasit Vectors; 2015 Dec; 8():624. PubMed ID: 26644133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign.
    Sykes ML; Baell JB; Kaiser M; Chatelain E; Moawad SR; Ganame D; Ioset JR; Avery VM
    PLoS Negl Trop Dis; 2012; 6(11):e1896. PubMed ID: 23209849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate as a novel quantitative measure of viability in Schistosoma mansoni drug sensitivity assays.
    Howe S; Zöphel D; Subbaraman H; Unger C; Held J; Engleitner T; Hoffmann WH; Kreidenweiss A
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1193-9. PubMed ID: 25487803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening.
    Abdulla MH; Ruelas DS; Wolff B; Snedecor J; Lim KC; Xu F; Renslo AR; Williams J; McKerrow JH; Caffrey CR
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e478. PubMed ID: 19597541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting of insulin and venus kinase Receptors of Schistosoma mansoni for novel anti-schistosome therapy.
    Vanderstraete M; Gouignard N; Cailliau K; Morel M; Lancelot J; Bodart JF; Dissous C
    PLoS Negl Trop Dis; 2013; 7(5):e2226. PubMed ID: 23696913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans.
    Guzman MA; Rugel AR; Tarpley RS; Alwan SN; Chevalier FD; Kovalskyy DP; Cao X; Holloway SP; Anderson TJC; Taylor AB; McHardy SF; LoVerde PT
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008517. PubMed ID: 32810153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luminescence-Based, Low- and Medium-Throughput Assays for Drug Screening in Schistosoma mansoni Larval Stage.
    Guidi A; Gimmelli R; Bresciani A; Ruberti G
    Methods Mol Biol; 2020; 2151():219-227. PubMed ID: 32452008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds.
    Ritler D; Rufener R; Sager H; Bouvier J; Hemphill A; Lundström-Stadelmann B
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005618. PubMed ID: 28520724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-throughput colorimetric assay for detection of Schistosoma mansoni viability based on the tetrazolium salt XTT.
    Aguiar PHN; Fernandes NMGS; Zani CL; Mourão MM
    Parasit Vectors; 2017 Jun; 10(1):300. PubMed ID: 28637488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production.
    Guidi A; Saccoccia F; Gennari N; Gimmelli R; Nizi E; Lalli C; Paonessa G; Papoff G; Bresciani A; Ruberti G
    Parasit Vectors; 2018 Dec; 11(1):668. PubMed ID: 30587243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Antischistosomal Leads Identified from in Vitro and in Vivo Screening of the Medicines for Malaria Venture Pathogen Box.
    Pasche V; Laleu B; Keiser J
    ACS Infect Dis; 2019 Jan; 5(1):102-110. PubMed ID: 30398059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of hit compounds with anti-schistosomal activity on in vitro generated juvenile worms in cell-free medium.
    Vejzagić N; Prodjinotho UF; El-Khafif N; Huang R; Simeonov A; Spangenberg T; Prazeres da Costa C
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009432. PubMed ID: 34033658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated imaging and other developments in whole-organism anthelmintic screening.
    Paveley RA; Bickle QD
    Parasite Immunol; 2013; 35(9-10):302-13. PubMed ID: 23581722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and Phenotypical Characterization of
    Saccoccia F; Brindisi M; Gimmelli R; Relitti N; Guidi A; Saraswati AP; Cavella C; Brogi S; Chemi G; Butini S; Papoff G; Senger J; Herp D; Jung M; Campiani G; Gemma S; Ruberti G
    ACS Infect Dis; 2020 Jan; 6(1):100-113. PubMed ID: 31661956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis.
    Li T; Ziniel PD; He PQ; Kommer VP; Crowther GJ; He M; Liu Q; Van Voorhis WC; Williams DL; Wang MW
    Infect Dis Poverty; 2015 Aug; 4():40. PubMed ID: 26341081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a human-serum-based in vitro growth method for drug screening on juvenile development stages of Schistosoma mansoni.
    Buchter V; Schneeberger PHH; Keiser J
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009313. PubMed ID: 33784302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.